STAAR Surgical Company  

(Public, NASDAQ:STAA)   Watch this stock  
Find more results for Staar Surgical Co.�
-0.02 (-0.11%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 17.29 - 17.73
52 week 6.10 - 19.50
Open 17.53
Vol / Avg. 150,897.00/349,434.00
Mkt cap 664.42M
P/E 1,817.24
Div/yield     -
EPS 0.01
Shares 37.97M
Beta -0.08
Inst. own 78%
Apr 28, 2014
Q1 2014 Staar Surgical Co Earnings Release (Estimated) Add to calendar
Mar 3, 2014
Staar Surgical Co at Cowen Health Care Conference - Webcast
Feb 26, 2014
Q4 2013 Staar Surgical Co Earnings Conference Call - Webcast
Feb 26, 2014
Q4 2013 Staar Surgical Co Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '14) 2014
Net profit margin -4.62% 0.55%
Operating margin -6.60% 0.97%
EBITD margin - 3.95%
Return on average assets -5.79% 0.68%
Return on average equity -9.17% 1.13%
Employees 301 -
CDP Score - -


1911 Walker Ave
United States - Map
+1-626-3037902 (Phone)
+1-626-3032962 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye. The Company is the maker of lenses used worldwide in corrective or refractive surgery. It also makes lenses for use in surgery that treats cataracts. All of the lenses it makes are foldable, which permits the surgeon to insert them through a small incision during minimally invasive surgery. Refractive surgery corrects the types of visual disorders that glasses or contact lenses have traditionally treated. It refers to its lenses used in refractive surgery as implantable Collamer lenses (ICLs). The field of refractive surgery includes both lens-based procedures, using products like its ICL, and laser-based procedures like laser-assisted in-situ keratomileusis (LASIK). STAAR�s principal products are intraocular lens (IOLs) and ICLs used in ophthalmic surgery.

Officers and directors

Mark B. Logan Independent Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Barry G. Caldwell President, Chief Executive Officer, Director
Age: 62
Bio & Compensation  - Reuters
Stephen P. Brown Chief Financial Officer, Vice President
Age: 54
Bio & Compensation  - Reuters
Hans-Martin Blickensdoerfer President, Europe, Middle East, Africa, Latin America
Age: 48
Bio & Compensation  - Reuters
Donald J. Todd President, Asia Pacific
Age: 59
Bio & Compensation  - Reuters
Deborah J. Andrews Chief Accounting Officer, Vice President
Age: 55
Bio & Compensation  - Reuters
Paul Hambrick Vice President - Global Operations
Age: 50
Bio & Compensation  - Reuters
Philippe Subrin Vice President - Switzerland Operations
Age: 49
Bio & Compensation  - Reuters
Samuel J. Gesten Vice President, General Counsel, Corporate Compliance Officer and Secretary
Age: 51
Bio & Compensation  - Reuters
Robin Hughes Vice President - Global Research and Development, Regulatory and Quality
Age: 49
Bio & Compensation  - Reuters